Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo

STUDY OBJECTIVES: This randomized, double-blind, placebo-controlled, crossover study was conducted to evaluate the safety and efficacy of 2 weeks of nightly sublingual cannabinoid extract (ZTL-101) in treating chronic insomnia (symptoms ≥3 months). METHODS: Co-primary study endpoints were safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Jennifer H, Maddison, Kathleen J, Rankin, Tim, Murray, Kevin, McArdle, Nigel, Ree, Melissa J, Hillman, David R, Eastwood, Peter R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Insomnia and Psychiatric Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598183/
https://www.ncbi.nlm.nih.gov/pubmed/34115851
http://dx.doi.org/10.1093/sleep/zsab149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598183/
https://www.ncbi.nlm.nih.gov/pubmed/34115851
http://dx.doi.org/10.1093/sleep/zsab149

Ejemplares similares